menu
    • menu

    Company profile for Vigene Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vigene Biosciences, Inc. was founded in 2012 to provide services and products to support the rapidly growing field of gene therapy. At the time, adenovirus was the primary viral vector used, so Vigene developed cloning technologies to generate the largest collection of full-length human open reading frames packaged in adenovirus. Over the next few years, different viral vectors became more widely used for research, so Vigene e...
    Vigene Biosciences, Inc. was founded in 2012 to provide services and products to support the rapidly growing field of gene therapy. At the time, adenovirus was the primary viral vector used, so Vigene developed cloning technologies to generate the largest collection of full-length human open reading frames packaged in adenovirus. Over the next few years, different viral vectors became more widely used for research, so Vigene expanded its viral packaging and cloning services to include the major viral vectors being used for gene delivery (AAV, adenovirus, lentivirus, and retrovirus).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vigene BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Research Court Rockville, MD 20850
    Telephone
    Telephone
    +1-301-251-6638
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vigenebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Charles River keeps adding on to its CDMO arm, snatching up viral vector player
    Charles River keeps adding on to its CDMO arm, snatching up viral vector player

    18 May 2021

    // Josh Sullivan ENDPTS

    https://endpts.com/charles-river-keeps-adding-on-to-its-cdmo-arm-snatching-up-a-viral-vector-player-for-a-tidy-350m/

    Josh Sullivan ENDPTS
    18 May 2021
    Share Share
    Charles River to Acquire Vigene Biosciences for up to $350 million
    Charles River to Acquire Vigene Biosciences for up to $350 million

    17 May 2021

    // PHARMTECH

    https://www.pharmtech.com/view/charles-river-to-acquire-vigene-biosciences-for-up-to-350-million

    PHARMTECH
    17 May 2021
    Share Share
    Altimmune and CDMO Vigene Enter COVID-19 Vax Pact
    Altimmune and CDMO Vigene Enter COVID-19 Vax Pact

    03 Aug 2020

    // CONTRACTPHARM

    https://www.contractpharma.com/contents/view_breaking-news/2020-08-03/altimmune-and-cdmo-vigene-enter-covid-19-vax-pact/

    CONTRACTPHARM
    03 Aug 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search